Objective: To compare angiotensin-converting enzyme (ACE) inhibitor use in patients with type 2 diabetes at 1 year and 3 years after guidelines were published.
Study Design: Retrospective database review.
Patients And Methods: The drug utilization review database of a state managed care plan was accessed to retrieve 2 random samples of 500 patients each.